Department of Pharmaceutical Quality Assurance, Nootan College of Pharmacy, Kavthe Mahakal, India 416405.
Inflammation is a central feature of many chronic diseases including arthritis, immune-mediated disorders, and cardiovascular conditions. This study aims to prepare and evaluate the anti-inflammatory properties of a novel polyherbal churna composed of Ashwagandha, Nirgundi, and Sunthi. The herbs were authenticated and processed as per Ayurvedic procedures. The powdered ingredients were mixed in the ratio 2:1:1 (Ashwagandha: Nirgundi: Sunthi) and evaluated through organoleptic, physicochemical, and phytochemical tests. Anti-inflammatory activity was assessed using protein denaturation assay [1] . The B2 batch showed 53.24% inhibition at 100 µg/ml concentration in protein denaturation assay, compared to 61.68% for Diclofenac sodium. The IC50 of the B2(Ashwagandha and Nirgund) batch was found to be 94.32 µg/ml. The results validate the traditional use of polyherbal churna for anti-inflammatory activity and highlight its potential as a safer alternative to synthetic drugs [2].
1.1 Polyherbal Churna: Definition and Significance in Traditional Medicine Ayurveda and other alternative medicine systems have traditionally used polyherbal churna, a finely ground combination made of several therapeutic plants. Combining several herbs increases medicinal efficacy while reducing side effects, according to the theory of polyherbalism. Polyherbal formulations, as opposed to single-herb therapies, utilize the various bioactive substances found in various plants to provide a wide range of therapeutic benefits [3]
1.2 Polyherbal churnas are used in traditional medicine, including Ayurveda, to treat a range of diseases, including as immune system imbalances, respiratory disorders, digestive problems, and inflammation. These formulations have a long history of therapeutic use and are frequently made from ancient writings that have been handed down through the generations. These conventional therapies have begun to be tested by modern research, showing their potential in modern medicine.
Historical Churnas and Ayurvedic Texts
Some well-known historical churnas that are mentioned in Ayurvedic literature include:
Triphala Churna: for purifying and digestion
Avipattikar Churna: for digestion and acidity
Sitopaladi Churna -for the sake of respiratory health [4]
2. MATERIAL AND METHOD:
2.1 Herbal Components:
1. Ashwagandha [5]. –
Table No.1
Parameter |
Details |
Common Name |
Ashwagandha |
Scientific Name |
Withania somnifera |
Family |
Solanaceae |
Description of the Plant |
This little shrub has yellow flowers and is used medicinally for its roots and berries. |
Nutritional Content |
Contains withanolides, alkaloids, iron, and amino acids |
Pharmacological Properties |
Adaptogenic, Anti-stress, Anti-inflammatory, Antioxidant |
Uses |
Used to reduce stress, boost energy, enhance stamina, and improve immunity |
2. Nirgundi [6] –
Table No.2
Parameter |
Details |
Common Name |
Nirgundi |
Scientific Name |
Vitex negundo |
Family |
Verbenaceae |
Plant Description |
3 m tall shrub or small tree; trifoliate or pentafoliate leaves with hair |
Nutritional Content |
High in stable Vitamin C; various bioactive compounds |
Pharmacological Properties |
Antioxidant, Antihistamine, Anti-inflammatory, Analgesic |
Uses |
External use for pain relief, antimicrobial protection, wound healing, internal medicinal use |
3. Sunthi [7] –
Table No.3
Parameter |
Details |
Common Name |
Sunthi (Dry Ginger) |
Scientific Name |
Zingiber officinale |
Family |
Zingiberaceae |
Plant Description |
Underground rhizome of the ginger plant; pale yellow to brown in color |
Nutritional Content |
Rich in gingerol, shogaol, and essential oils |
Pharmacological Properties |
Anti-inflammatory, Antioxidant, Digestive aid, Anti-nausea |
Uses |
Used in digestive disorders, colds, sore throat, inflammation, and as a spice |
2.2 How to prepare churna:
The formulation was created using raw materials such 15g of ashwagandha (Withania somnifera), 7.5g of nirgundi (Vitex negundo), and 7.5g of Sunthi (Zingiber officinale). The microscopic features of the powdered medicine are employed for authentication. The material was finally ground. After applying filter number 60, the final powdered raw materials were combined in the proper ratio of 15 grams of ashwagandha, 7.5 grams of nirgundi, and 7.5 grams of Sunthi. An airtight container was used to store the churna [8].
2.3 Preparation Procedure: -
Drying: Powders are dried after grinding.
Size Reduction: Raw materials are ground using a powered mixer.
Weighing: Ingredients are measured some in small, others in large quantities depending on the batch.
Mixing: All weighed ingredients are mixed thoroughly.
Filling: The final churna is transferred to the filling section and measured.
Packaging: Products are packed, labeled with details, and sent to the warehouse for delivery [9] .
2.4 Anti-Inflammatory Assay:
Experimental process:
Protein denaturation technique for in vitro anti-inflammatory activity 0.4 mL of fresh hen's egg albumin, 5.6 mL of phosphate buffered saline (PBS, pH 6.4), and 100 µL of a sample with varying concentrations made up the reaction mixture (10 mL). As a control, a comparable volume of double-distilled water was used. After 15 minutes of incubation at 370°C, the mixtures were heated to 70°C for five minutes. After cooling, the vehicle was used as a blank to measure their absorbance at 660 nm. In order to determine absorbance, diclofenac sodium at the concentration was used as a reference medication and handled identically. Description of the Plant This little shrub has yellow flowers and is used medicinally for its roots and berries.
% Inhibition = C –T/
Where,
T = absorbance of test sample
C = absorbance of control
3. RESULT:
3.1 Observation Table-
Table No.4
Sr. No |
Sample Code |
Concentrations (µg) |
1 |
B1: B2 |
500:500 (µg) |
2 |
B2: B3 |
500:500 (µg) |
3 |
B3: B1 |
500:500 (µg) |
(B1: Sunt Powder B2: Ashwagandha Powder B3: Nirgundi Powder) As indicated in the table below, the various concentrations of the provided samples were first combined and homogenized using a vortex mixer. Following homogenized powder compound production and testing for anti-inflammatory efficacy, the B2 (Ashwagandha and Nirgundi) batch was selected for additional research based on a preliminary screening.
3.2 Observation Table:
Table No.5
|
|
|
Protein Denaturation Assay |
|
|||||
Sr. No |
Sample code |
Concentration (µg/ml) |
Absorbance at 660nm |
|
|
|
|||
|
|
|
Test 1 |
Test 2 |
Test 3 |
Mean |
% Inhibition |
IC50 (µg/ml) |
|
1 |
Control |
|
1.54 |
1.54 |
1.54 |
1.54 |
- |
76.11 |
|
2 |
Standard (Diclofenac Sodium) |
20 |
1.43 |
1.44 |
1.43 |
1.43 |
7.14% |
|
|
|
|
40 |
1.20 |
1.20 |
1.22 |
1.20 |
22.07% |
|
|
|
|
60 |
0.96 |
0.97 |
0.98 |
0.97 |
37.01% |
|
|
|
|
80 |
0.72 |
0.72 |
0.71 |
0.71 |
53.89% |
|
|
|
|
100 |
0.59 |
0.61 |
0.59 |
0.59 |
61.68% |
|
|
3 |
B2 (mix batch) |
20 |
1.33 |
1.36 |
1.38 |
1.35 |
12.33% |
94.32 |
|
|
|
40 |
1.28 |
1.26 |
1.30 |
1.28 |
16.88% |
||
|
|
60 |
0.96 |
0.98 |
0.94 |
0.96 |
37.66% |
||
|
|
80 |
0.84 |
0.85 |
0.87 |
0.85 |
44.80% |
||
|
|
100 |
0.72 |
0.72 |
0.72 |
0.72 |
53.24% |
3.3 Graphical Data
Fig No. 1
3.4 Images of the Activity:
Fig No. 2
Fig.no. 3
3.5 Evaluation Parameters:
1. Ashwagandha [10]
Table No.6
Sr. No. |
Phytochemical Test |
Reagent/Method |
Observation (Positive Result) |
1 |
Mayer’s Test (Alkaloids) |
Mayer’s reagent (Potassium mercuric iodide) + extract |
Cream-colored precipitate indicates presence of alkaloids |
2 |
Wagner's Alkaloids |
TestIodine in KI, Wagner's reagent, plus extract |
The presence of alkaloids is indicated by a reddish-brown precipitate. |
3 |
Dragendorff’s Test (Alkaloids) |
Dragendorff’s reagent + extract |
Orange or red precipitate indicates presence of alkaloids |
4 |
Hager’s Test (Alkaloids) |
Hager’s reagent (Saturated picric acid) + extract |
Yellow precipitate indicates presence of alkaloids |
5 |
Foam Test (Saponins) |
Shake extract with water |
Persistent foam indicates presence of saponins |
2. Nirgundi [11]
Table No.7
Sr. No. |
Phytochemical Test |
Reagent/Method |
Observation (Positive Result) |
1 |
Mayer’s Test (Alkaloids) |
Mayer’s reagent (Potassium mercuric iodide) + extract |
Cream-colored precipitate indicates presence of alkaloids |
2 |
Wagner’s Test (Alkaloids) |
Wagner’s reagent (Iodine in KI) + extract |
Reddish-brown precipitate indicates presence of alkaloids |
3 |
Dragendorff’s Test (Alkaloids) |
Dragendorff’s reagent + extract |
Orange or red precipitate indicates presence of alkaloids |
4 |
Hager’s Test (Alkaloids) |
Hager’s reagent (Saturated picric acid) + extract |
Yellow precipitate indicates presence of alkaloids |
5 |
Foam Test (Saponins) |
Shake extract with water |
Persistent foam indicates presence of saponins |
3.Sunthi [12]
Table No.8
Sr. No. |
Phytochemical Test |
Reagent/Method |
Observation (Positive Result) |
1 |
Mayer’s Test (Alkaloids) |
Mayer’s reagent (Potassium mercuric iodide) + extract |
Cream-colored precipitate indicates presence of alkaloids |
2 |
Wagner’s Test (Alkaloids) |
Wagner’s reagent (Iodine in KI) + extract |
Reddish-brown precipitate indicates presence of alkaloids |
3 |
Dragendorff’s Test (Alkaloids) |
Dragendorff’s reagent + extract |
Orange or red precipitate indicates presence of alkaloids |
4 |
Hager's (Alkaloids) Test |
Saturated picric acid, Hager's reagent, plus extract Alkaloids are present |
yellow precipitate forms. |
5 |
Saponins Foam Test |
Mix the extract with water |
The presence of saponins is indicated by persistent froth. |
3.6 Moisture content [13]
Table No.9
Parameter |
Ashwagandha Powder |
Sunthi Powder |
Nirgundi Powder |
Petri Dish Preparation |
105°C for 20 min |
105°C for 20 min |
105°C for 20 min |
Sample Preparation |
3 gm |
3 gm |
3 gm |
Using a hot air oven for drying |
±35°C for 20 min |
±35°C for 20 min |
±35°C for 20 min |
Weight of Sample + Crucible (Ws) |
31 g |
31 g |
31 g |
Drying (Hot Air Oven) |
±35°C for 20 min |
±35°C for 20 min |
±35°C for 20 min |
Weight of Sample + Crucible (Ws) |
31 g |
31 g |
31 g |
Weight of Crucible (W1) |
28 g |
28 g |
28 g |
Weight of Crucible + Dry Sample (W2) |
30.40 g |
29.92 g |
29.68 g |
Moisture Content Calculation |
Value 1 |
Value 2 |
Value 3 |
((Ws - W2) / (Ws - W1)) × 100 = |
93.61% |
94.58% |
92.25% |
3.7 Ash content [14]
Table No.10
Powder |
Ash % |
Ashwagandha Powder |
39.00% |
Sunthi Powder |
16.33% |
Nirgundi Powder |
5.00% |
4. DISCUSSION:
The polyherbal churna demonstrated significant anti-inflammatory activity, especially the B2 (Ashwagandha and Nirgund) batch, which combined synergistic effects of the three herbs. The formulation adhered to traditional Ayurvedic methods while undergoing modern analytical validation. The results endorse its use as an effective natural remedy.
5. CONCLUSION:
The study successfully formulated and evaluated a polyherbal churna composed of Ashwagandha (Withania somnifera), Nirgundi (Vitex negundo), and Sunthi (Zingiber officinale) for its anti-inflammatory potential. The formulation process adhered to Ayurvedic principles and included standard authentication and quality control methods. In-vitro protein denaturation assays demonstrated significant anti-inflammatory activity, especially in the B2 (Ashwagandha and Nirgund) batch formulation, which showed notable percentage inhibition compared to the standard drug (Diclofenac sodium). These results support the traditional use of these herbs and suggest that such polyherbal formulations can serve as effective, natural alternatives to synthetic anti-inflammatory drugs with minimal side effects.
6. ACKNOWLEDGMENTS:
I would like to sincerely thank everyone who supported and guided me throughout the "Preparation and Testing of an Anti-Inflammatory Herbal Churna" project. First and foremost, I am deeply grateful to Tahira Malidwale for her invaluable advice, unwavering support, and continuous supervision, which played a crucial role in the successful completion of this work. Her motivation and wise counsel were invaluable during the endeavor. I would also like to extend my heartfelt thanks to the faculty and laboratory staff of the Department of Quality Assurance at Nootan College of Pharmacy, Kavthe Mahankal, for providing the necessary facilities and resources for conducting the experimental study.My sincere gratitude goes to my family and friends for their constant support, understanding, and moral encouragement throughout this academic journey. Finally, I would like to acknowledge the contributions of researchers and authors of the reference materials, whose work greatly assisted me in understanding and executing this project.
REFERENCES
Yogesh Chavan*, Anuja Patil, Tahira Malidwale, Gauri Waydande, Bhagyashri Yamgar, Exploring the Anti-Inflammatory Efficacy of a Novel Polyherbal Churna, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 5, 4438-4445. https://doi.org/10.5281/zenodo.15532211